Contrast-Enhanced Sonography Using Levovist is Decisive for Staging and Therapeutic Schedule in Hepatocellular Carcinoma;Kontrastmittelsonographie der Leber als Wegweisende Untersuchung für die Therapieplanung des Hepatozellulären Karzinoms

Medizinische Klinik

Volumn 99, Issue 2, 2004, Pages 89-92

  Von Herbay, Alexandra ^a,b   Donner, Andreas ^a   Jung, Gregor ^a   Vogt, Christoph ^a   Häussinger, Dieter ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Contrast agents; Hepatocellular carcinoma; Levovist; Liver; Ultrasound

Indexed keywords

SHU 508; SUPERPARAMAGNETIC IRON OXIDE;

AGED; ARTICLE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HEMIHEPATECTOMY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MULTIPLE CANCER; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING;

AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; IRON; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; OXIDES; POLYSACCHARIDES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1242339618     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-004-1001-1     Document Type: Article

References (23)

1. Albrecht T, Hoffmann CW, Schettler S, et al. B-mode enhancement at phase-inversion US with air-based microbubble contrast agent: initial experience in humans. Radiology 2000;216:273-8.
2. von Herbay A, Vogt C, Häussinger D. Late-phase pulse-inversion sonography using the contrast agent Levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol 2002;179:1273-9.
3. Albrecht T, Hoffmann CW, Schettler S, et al. Improved detection of liver metastases with phase inversion imaging during the liver-specific phase of the ultrasound contrast agent Levovist. Eur Radiol 1999;9:Suppl 3:S388.
4. Schlief R. Developments in echo-enhancing agents. Clin Kadiol 1996;51:Suppl A:5-7.
5. Goldberg BB, Liu JB, Burns PN, et al. Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med 1993;12:463-70.
6. Blomley M, Albrecht T, Cosgrove D, et al. Stimulated acoustic emission imaging ("sono-scintigraphy") with the ultrasound contrast agent Levovist: a reproducible Doppler ultrasound effect with potential clinical utility. Acad Radiol 1998;5:Suppl 1:S236-9.
7. von Herbay A, Vogt C, Häussinger D. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist. J Ultrasound Med 2002; 21:1191-200.
8. Blomley MJK, Albrecht T, Cosgrove DO, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999;210:409-16.
9. Forsberg F, Goldberg BB, Liu J-B, et al. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. Radiology 1999;210:125-32.
10. Blomley MJK, Albrecht T, Cosgrove DO, et al. Stimulated acoustic emission in liver parenchyma with Levovist. Lancet 1998;351:568.
11. von Herbay A, Vogt C, Häussinger D. Differentiation between benign and malignant hepatic lesions by stimulated acoustic emissions (color-SAE) in the late phase of the ultrasound contrast agent Levovist. J Ultrasound Med 2004: in press.
12. Schlief R. Galactose-based echo-enhancing agents. In: Goldberg BB, ed. Ultrasound contrast agents. London: Dunitz, 1997:75-82.
13. Blomley MJ, Albrecht T, Cosgrove DO, et al. Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol 1999;25:1341-52.
14. De Jong N. Physics of microbubble scattering. In: Nanda N, Schlief R, Goldberg BB, eds. Advances in echo imaging using contrast enhancement, 2nd edn. Lancaster: Kluwer Academic, 1997:39-64.
15. Bauer A, Hauff P, Lazenby J, et al. Wideband harmonic imaging: a novel contrast ultrasound imaging technique. Eur Radiol 1999;9:Suppl 3:S364-7.
16. Hope-Simpson D, Chin CT, Burns PN. Pulse inversion Doppler: a new method for detecting non-linear echoes from microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Frequency Control 1999; 46:372-82.
17. Shi WT, Forsberg F. Ultrasonic characterization of the nonlinear properties of contrast microbubbles. Ultrasound Med Biol 2000;26:93-104.
18. Burns PN, Powers JE, Hope-Simpson D, et al. Harmonic imaging: principles and preliminary results. Angiology 1996;47:63-73.
19. Mazzaferro JW, Regalia E, Doci K, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients wich cirrhosis. N Engl J Med 1996;334:693-9.
20. Fihueras J, Jaurrieta E, Valls C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997;25:1485-9.
21. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002;122:1609-19.
22. Campani R, Calliada F, Bottinelli O, et al. Improved ultrasound sensitivity in detecting focal liver lesions by B-mode harmonic imaging and contrast enhancement. Radiology 1998;209:Suppl:232.
23. Harvey C, Blomley MJK, Eckersley RJ, et al. Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet 2000;355:807-8.